These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32825059)

  • 1. Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis.
    Pallio G; Mannino F; Irrera N; Eid AH; Squadrito F; Bitto A
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32825059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.
    Tarnowski M; Paradowska-Gorycka A; Dąbrowska-Zamojcin E; Czerewaty M; Słuczanowska-Głąbowska S; Pawlik A
    Expert Opin Drug Metab Toxicol; 2016; 12(1):41-55. PubMed ID: 26609565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of biological treatment in rheumatoid arthritis.
    Xie X; Zhang D; Chen JW; Tian J; Ling GH; Li F
    Expert Opin Biol Ther; 2014 Feb; 14(2):157-64. PubMed ID: 24295560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
    Bek S; Bojesen AB; Nielsen JV; Sode J; Bank S; Vogel U; Andersen V
    Pharmacogenomics J; 2017 Oct; 17(5):403-411. PubMed ID: 28607508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment.
    Marwa OS; Kalthoum T; Wajih K; Kamel H
    Immunol Lett; 2017 Mar; 183():24-36. PubMed ID: 28143790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in rheumatoid arthritis.
    Sen D; Paul JR; Ranganathan P
    Methods Mol Biol; 2014; 1175():625-60. PubMed ID: 25150878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.
    Malik F; Ranganathan P
    Pharmacogenomics; 2013 Feb; 14(3):305-14. PubMed ID: 23394392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.
    Ranganathan P
    Pharmacogenomics; 2005 Jul; 6(5):481-90. PubMed ID: 16013998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting response to TNF antagonists in rheumatoid arthritis: the promise of pharmacogenetics research using clinical registries.
    Greenberg JD; Ostrer H
    Bull NYU Hosp Jt Dis; 2007; 65(2):139-42. PubMed ID: 17581108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.
    Atzeni F; Talotta R; Masala IF; Gerardi MC; Casale R; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):500-510. PubMed ID: 31174819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine (IL-6) and chemokine (IL-8) gene polymorphisms among rheumatoid arthritis patients in Taiwan.
    Lo SF; Huang CM; Lin HC; Chen WC; Tsai CH; Tsai FJ
    Clin Exp Rheumatol; 2008; 26(4):632-7. PubMed ID: 18799095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in treatment of rheumatoid arthritis.
    Kooloos WM; Huizinga TW; Guchelaar HJ; Wessels JA
    Curr Pharm Des; 2010; 16(2):164-75. PubMed ID: 20205662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.
    Zhu H; Deng FY; Mo XB; Qiu YH; Lei SF
    Pharmacogenomics; 2014 Mar; 15(4):551-66. PubMed ID: 24624921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
    Wessels JA; van der Kooij SM; le Cessie S; Kievit W; Barerra P; Allaart CF; Huizinga TW; Guchelaar HJ;
    Arthritis Rheum; 2007 Jun; 56(6):1765-75. PubMed ID: 17530705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 2)].
    Swierkot J; Slęzak R
    Postepy Hig Med Dosw (Online); 2011 Mar; 65():207-15. PubMed ID: 21502697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of therapies in rheumatoid arthritis.
    Ranganathan P
    Drugs Today (Barc); 2005 Dec; 41(12):799-814. PubMed ID: 16474855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in the genetic diagnostics of rheumatoid arthritis.
    Nagy ZB; Csanád M; Tóth K; Börzsönyi B; Demendi C; Rigó J; Joó JG
    Expert Rev Mol Diagn; 2010 Jul; 10(5):603-18. PubMed ID: 20629510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on methotrexate pharmacogenetics in rheumatoid arthritis.
    Ranganathan P
    Pharmacogenomics; 2008 Apr; 9(4):439-51. PubMed ID: 18384257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy.
    Wysocki T; Paradowska-Gorycka A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
    Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
    Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.